NCT02342158 2026-04-21
PERMED01
Institut Paoli-Calmettes
Phase NA Completed
Clinical Trials
4 trialsNCT05107219 2026-04-07
GCC Agonist Signal in the Small Intestine
University of Wisconsin, Madison
Phase 1 Completed
NCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
NCT02613962 2026-04-01
MAPPYACTS
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed